North America Biomedical Refrigerators and Freezers Market Size & Share 2025 – 2034

North America Biomedical Refrigerators and Freezers Market Size

The North America biomedical refrigerators and freezers market was valued at USD 1.6 billion in 2024 and is projected to grow from USD 1.7 billion in 2025 to USD 2.6 billion by 2034, expanding at a CAGR of 5.1%, according to the latest report published by Global Market Insights Inc.

This steady growth is stimulated by various factors such as ongoing technological innovations, rising demand for biopharmaceuticals, and an increasing number of organ transplants across the region. These devices are essential to store vaccines, medication, samples, and other temperature-sensitive materials under precise and optimal conditions in order to maintain the integrity and efficacy of the material. Major companies in the industry include Thermo Fisher Scientific, Helmer Scientific, PHC, Eppendorf, and Follett Products.
 

The market increased from USD 1.4 billion in 2021 to USD 1.5 billion in 2023. This growth is highly stimulated by the rising prevalence of chronic diseases in North America, such as diabetes, cancer, cardiovascular conditions, and infectious diseases. These conditions significantly increase the need for biomedical freezers, as these devices are critical for storing medications, biological samples, and other sensitive materials used in both treatment and research. For instance, according to the Centers for Disease Control and Prevention (CDC), 38.4 million individuals of all ages, or 11.6% of the U.S. population, had diabetes in 2021.
 

This growing burden of chronic illnesses such as diabetes is creating demand for reliable biomedical storage solutions for the storage of biologic, such as insulin, which is estimated to reach USD 43 billion by 2034, thereby accelerating the growth of the biomedical refrigerators and freezers market across North America.
 

Moreover, the rapidly growing elderly population in North America is a major factor driving the demand for biomedical refrigerators and freezers. Individuals aged 65 and older are more likely to suffer from chronic conditions, which require frequent medical intervention and the use of temperature-sensitive medications and biological products. For instance, according to the Population Reference Bureau, the number of individuals aged 65 and older in the U.S. is expected to rise from 58 million in 2022 to 82 million by 2050, marking a 47% increase.
 

Additionally, this age group’s share of the total population is projected to grow from 17% to 23%, highlighting a significant demographic shift. Thus, as the elderly population expands, so does the need for reliable cold storage solutions to maintain the integrity of medications, vaccines, and other sensitive materials used in their treatment, thereby fostering market growth.
 

Biomedical refrigerators and freezers are essential devices used in pharmaceuticals, research, and healthcare industries. These devices are essential to store vaccines, medication, samples, and other temperature-sensitive materials under precise and optimal conditions in order to maintain the integrity and efficacy of the material.

North America Biomedical Refrigerators and Freezers Market Trends

• In North America, the biomedical refrigeration systems market is experiencing strong growth due to technological advancements that enable precise temperature control, real-time monitoring, and automated alert systems. These innovations ensure the safe and secure storage of biological materials, significantly reducing the risk of spoilage or contamination in healthcare and research settings.
   
• Additionally, modern biomedical refrigerators and freezers in the region are increasingly adopting energy-efficient and environmentally sustainable designs. The use of inverter compressors and eco-friendly refrigerants helps lower operational costs while aligning with North America’s environmental regulations, making these systems a preferred choice for hospitals, laboratories, and pharmaceutical facilities.
   
• For instance, Aegis Scientific’s Glacier Series, including models such as the GL-RG-50M Medical Refrigerator and GL-FL-19M Freezer, features advanced microprocessor-controlled temperature systems, and energy-efficient inverter compressors. These units offer excellent temperature uniformity and remote monitoring via Sentinel Next software.
   
• These advancements in precision control and sustainable design are not only enhancing the reliability and safety of biomedical storage but are also aligning with the evolving regulatory and operational needs of North America’s healthcare systems and research institutes. Therefore, these technological advancements are playing an important role in accelerating the continued growth of the biomedical refrigeration systems market across the region.
   

North America Biomedical Refrigerators and Freezers Market Analysis

The market was valued at USD 1.42 billion in 2021. The market size reached USD 1.52 billion in 2023, from USD 1.47 billion in 2022. Based on the product, the market is segmented into plasma freezers, blood bank refrigerators, lab refrigerators, lab freezers, ultra low temperature freezers, and shock freezers.
 

The lab refrigerators segment dominated the market in 2024, holding the largest share due to the widespread adoption across research laboratories, diagnostic centers, and hospitals for storing reagents, samples, and other temperature sensitive materials. This segment was valued at USD 426.4 million in 2024 and is projected to reach USD 717.2 million by 2034, growing at a CAGR of 5.4%. In comparison, the blood bank refrigerators segment, valued at USD 239 million in 2024, is expected to grow to USD 409.7 million by 2034, with a CAGR of 5.6%.
 

• Blood bank refrigerators are specialized medical refrigeration units designed to store blood and blood components, such as plasma and platelets, at precisely regulated temperatures. They help maintain the safety and usability of life-saving materials, making them essential for hospital blood banks and transfusion centers.
   
• In the North American market, the blood bank refrigerators segment has emerged as the fastest-growing segment within the biomedical refrigerators and freezers market. This growth is stimulated by the increasing demand for the safe and reliable storage of blood and plasma products, which are critical for transfusions, surgeries, and emergency care.
   
• For instance, according to the American Red Cross, approximately 29,000 units of red blood cells, 5,000 units of platelets, and 6,500 units of plasma are needed daily. In total, nearly 16 million blood components are transfused each year in the U.S., highlighting the critical demand for efficient and secure blood storage systems.
   
• This high and consistent demand for blood products is driving the adoption of blood bank refrigeration solutions across healthcare facilities in North America.
   
• Therefore, this segment is set to play an important role in the overall expansion of the biomedical refrigerators and freezers market in the region during the forecast period.
   

Learn more about the key segments shaping this market

Download Free PDF

Based on end use, the North America biomedical refrigerators and freezers market is segmented into blood banks, pharmacies, hospitals, research labs, diagnostic centers, and other end users. The diagnostic centers segment accounted for the highest market share of 36.8% in 2024.
 

• Diagnostic centers are healthcare facilities that perform a wide range of tests to diagnose various medical conditions. These facilities heavily rely on biomedical refrigerators and freezers to store biological samples and reagents used for testing.
   
• The dominance of this segment is attributed to the increasing demand for accurate testing and the secure storage of biological samples, such as blood, tissue, and genetic material.
   
• For example, as of 2024, there are 31,277 diagnostic and medical laboratories operating in the U.S., marking a 2.5% increase from 2023. This growth highlights the expanding need for advanced refrigeration systems to support high testing output and maintain sample integrity across a wide range of diagnostic procedures.
   
• The ongoing expansion of diagnostic services drives the demand for reliable and energy-efficient biomedical refrigerators and freezers, thereby stimulating market growth in North America.
   

The U.S. dominated the North America biomedical refrigerators and freezers market, with the highest market share of 91.1% in 2024.
 

• The increasing demand for biopharmaceuticals and organ transplantation is a key factor accelerating the growth of the biomedical refrigerators and freezers market in the region. These devices are essential for preserving temperature-sensitive biological materials, such as organs, tissues, vaccines, and advanced therapeutics used in transplantation and treatment.
   
• For instance, according to the United Network for Organ Sharing, there were more than 7,000 living donor transplants and over 17,000 deceased donors in the U.S. in 2024, reflecting the growing scale of organ transplantation.
   
• Thus, this rising volume of transplant procedures and the expanding use of biopharmaceuticals highlight the need for biomedical refrigerators and freezers solutions, thereby propelling market expansion across the country.
   

Canada biomedical refrigerators and freezers market was valued at USD 125.5 million and USD 130 million in 2021 and 2022, respectively. In 2024 the market size reached USD 141.7 million from USD 135.3 million in 2023.
 

• In Canada, chronic diseases such as diabetes are a major factor contributing to the rising demand for biomedical refrigerators and freezers. These devices are essential for storing insulin and other temperature-sensitive medications required for effective disease management.
   
• For instance, according to Diabetes Canada, 30% of Canadians live with either diabetes or prediabetes, and 10% have diagnosed diabetes.
   
• This high and growing prevalence of diabetes in Canada highlights the critical need for reliable cold storage solutions. Therefore, the demand for biomedical refrigerators and freezers is increasing, supporting better chronic disease care and driving market growth across the country.
   
• Additionally, the growing number of organ transplants in Canada is significantly contributing to the demand for biomedical refrigerators and freezers.
   
• For instance, according to the data from Health Canada, in 2022, a total of 2,936 solid organ transplants, including kidney, heart, lung, and liver, were performed in Canada, marking a 6.8% increase from 2021 and a 31.4% increase compared to a decade ago. This rising volume of organ transplants and the growing waitlist highlight the critical need for advanced biomedical refrigerators and freezers, stimulating the market growth.
   

North America Biomedical Refrigerators and Freezers Market Share

• The top 5 players in the market such as Thermo Fisher Scientific, Helmer Scientific, PHC, Eppendorf, and Follett Products collectively hold a 37.1% share of the North America market. These companies maintain their leadership through diverse product portfolios, strategic collaborations, regulatory approvals, and ongoing innovation. Thermo Fisher Scientific stands out due to their comprehensive range of biomedical refrigerators and freezers, widely adopted in hospitals and diagnostic centers.
   
• Thermo Fisher Scientific holds a competitive edge in the biomedical cold storage market with its TSX Universal Series ULT Freezers, designed to meet the evolving demands of modern research and clinical environments. These freezers feature Universal V-Drive technology for energy-efficient cooling, and optimized cabinet design for sample integrity. Their compact, high-capacity configurations support decentralized labs and point-of-care settings, aligning with sustainability goals and regulatory standards.
   
• New entrants are gaining traction in the market by leveraging innovation specialisation and strategy growth. Many are introducing advanced technologies such as IoT enabled monitoring, energy efficient cooling systems, and eco-friendly refrigerants to meet evolving regulatory and sustainability. Additionally, strategic partnership acquisition and brand integration also play a key role allowing new entrants to scale quickly and gain market credibility by aligning with established distributor merging with complimentary brand these companies expand their reach and streamline operations.
   

North America Biomedical Refrigerators and Freezers Market Companies

Few of the prominent players operating in the North America biomedical refrigerators and freezers industry include:

• Aegis Scientific
• Azbil
• B Medical Systems
• Eppendorf
• Follett Products
• Helmer Scientific
• Lab Research Products
• Migali Scientific
• NuAire
• PHC
• Powers Scientific
• So-Low Environmental Equipment
• Stirling Ultracold
• Thermo Fisher Scientific
   
• Eppendorf

Eppendorf serves the North American biomedical sector with advanced cold storage solutions tailored for research and clinical applications. The company emphasizes energy efficiency, sample integrity, and compliance with regional standards. One of its leading products, the CryoCube F740 ULT Freezer, provides ultra-low temperature storage at -80°C, combining high capacity with low energy consumption.
 

• Follett Products

Follett Products supports the North American healthcare and life sciences sectors with specialized refrigeration solutions designed for vaccine storage, clinical labs, and point-of-care environments. The company is known for its compact, energy-efficient units that meet stringent performance standards.
 

• Stirling Ultracold

Stirling Ultracold provides ultra-low temperature storage solutions across North America, serving biorepositories, clinical research, and pharmaceutical cold chains. The company’s freezers use Stirling engine technology instead of traditional compressors, offering precise cooling from -20°C to -86°C with significantly lower energy consumption. A widely used model is the SU780XLE ULT Freezer, which combines high storage capacity with sustainability and reliability, making it suitable for preserving vaccines, biological samples, and temperature-sensitive materials in demanding lab environments.
 

North America Biomedical Refrigerators and Freezers Industry News:

• In February 2025, Follett Products expanded its manufacturing capabilities in Lehigh Valley, PA by adding a new facility in Denver, CO. As part of this expansion, Kloppenberg, a well-known brand under the Middle by ice portfolio, was brought under Follett’s operations and began utilizing the existing Colorado facility. The combined operations were named Follett Denver, serving the market with both Follett and Kloppenberg products. This strategic move gave the company a competitive edge in the market.
   
• In February 2024, PHC Corporation of North America (PHCNA), a supplier of PHCbi brand cell preservation and growth products across North and Latin America, launched a new model in its PHCbi VIP ECO SMART ultra-low temperature (ULT) freezer series. Designed for use in medical institutions, universities, and pharmaceutical companies, this strategic initiative expanded the company’s product portfolio in the region.
   

The North America biomedical refrigerators and freezers market research report includes in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million and from 2021 - 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Plasma freezers
• Blood bank refrigerators
• Lab refrigerators
• Lab freezers
• Ultra low temperature freezers
• Shock freezers

Market, By End Use

• Blood banks
• Pharmacies
• Hospitals
• Research labs
• Diagnostic centers
• Other end users

The above information is provided for the following countries:

• U.S.
• Canada